Sign In
Buy G
Genpact Earnings Calls
| Release date | May 07, 2026 |
| EPS estimate | $0.93 |
| EPS actual | $0.98 |
| EPS Surprise | 5.38% |
| Revenue estimate | 1.289B |
| Revenue actual | 1.296B |
| Revenue Surprise | 0.524% |
| Release date | Feb 05, 2026 |
| EPS estimate | $0.93 |
| EPS actual | $0.97 |
| EPS Surprise | 4.30% |
| Revenue estimate | 1.308B |
| Revenue actual | 1.319B |
| Revenue Surprise | 0.84% |
| Release date | Nov 06, 2025 |
| EPS estimate | $0.90 |
| EPS actual | $0.97 |
| EPS Surprise | 8.02% |
| Revenue estimate | 1.266B |
| Revenue actual | 1.291B |
| Revenue Surprise | 2.00% |
| Release date | Aug 07, 2025 |
| EPS estimate | $0.85 |
| EPS actual | $0.88 |
| EPS Surprise | 3.53% |
| Revenue estimate | 1.255B |
| Revenue actual | 1.254B |
| Revenue Surprise | -0.0625% |
Last 4 Quarters for Genpact
Below you can see how G performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Aug 07, 2025 |
| Price on release | $41.72 |
| EPS estimate | $0.85 |
| EPS actual | $0.88 |
| EPS surprise | 3.53% |
| Date | Price |
|---|---|
| Aug 01, 2025 | $42.49 |
| Aug 04, 2025 | $42.55 |
| Aug 05, 2025 | $42.37 |
| Aug 06, 2025 | $42.20 |
| Aug 07, 2025 | $41.72 |
| Aug 08, 2025 | $43.54 |
| Aug 11, 2025 | $43.25 |
| Aug 12, 2025 | $43.31 |
| Aug 13, 2025 | $44.22 |
| 4 days before | -1.81% |
| 4 days after | 5.99% |
| On release day | 4.36% |
| Change in period | 4.07% |
| Release date | Nov 06, 2025 |
| Price on release | $38.39 |
| EPS estimate | $0.90 |
| EPS actual | $0.97 |
| EPS surprise | 8.02% |
| Date | Price |
|---|---|
| Oct 31, 2025 | $38.15 |
| Nov 03, 2025 | $38.12 |
| Nov 04, 2025 | $38.43 |
| Nov 05, 2025 | $38.82 |
| Nov 06, 2025 | $38.39 |
| Nov 07, 2025 | $44.49 |
| Nov 10, 2025 | $44.28 |
| Nov 11, 2025 | $44.89 |
| Nov 12, 2025 | $45.54 |
| 4 days before | 0.629% |
| 4 days after | 18.62% |
| On release day | 15.89% |
| Change in period | 19.37% |
| Release date | Feb 05, 2026 |
| Price on release | $37.70 |
| EPS estimate | $0.93 |
| EPS actual | $0.97 |
| EPS surprise | 4.30% |
| Date | Price |
|---|---|
| Jan 30, 2026 | $44.10 |
| Feb 02, 2026 | $44.13 |
| Feb 03, 2026 | $38.97 |
| Feb 04, 2026 | $38.34 |
| Feb 05, 2026 | $37.70 |
| Feb 06, 2026 | $40.39 |
| Feb 09, 2026 | $39.49 |
| Feb 10, 2026 | $39.14 |
| Feb 11, 2026 | $37.18 |
| 4 days before | -14.51% |
| 4 days after | -1.38% |
| On release day | 7.14% |
| Change in period | -15.69% |
| Release date | May 07, 2026 |
| Price on release | $34.48 |
| EPS estimate | $0.93 |
| EPS actual | $0.98 |
| EPS surprise | 5.38% |
| Date | Price |
|---|---|
| May 01, 2026 | $34.33 |
| May 04, 2026 | $34.14 |
| May 05, 2026 | $34.08 |
| May 06, 2026 | $33.80 |
| May 07, 2026 | $34.48 |
| May 08, 2026 | $32.56 |
| May 11, 2026 | $31.30 |
| May 12, 2026 | $31.25 |
| May 13, 2026 | $29.44 |
| 4 days before | 0.437% |
| 4 days after | -14.62% |
| On release day | -5.57% |
| Change in period | -14.24% |
Genpact Earnings Call Transcript Summary of Q1 2026
Genpact reported a strong Q1 2026 with total revenue up 6.7% year-over-year to $1.296B and notable acceleration in Advanced Technology Solutions (ATS), which grew 24% YoY to $345M and now represents 27% of revenue. Management highlighted rapid traction in agentic (AI-driven) offerings — nearly doubling agentic contract value versus all of 2025 — and increasing annuitized, non-FTE revenue (non-FTE was 48% of total revenue). Gross margin expanded ~110 bps to 36.4% (12th consecutive quarter of expansion) and adjusted diluted EPS grew 16.7% to $0.98. Bookings, backlog and pipeline are at record levels; the company signed six large deals in the quarter and emphasized partner-led growth (partner-related revenue +35% YoY, ~13% of revenue), including a strategic alliance with Google for CFO/finance solutions. Management expects at least 7% revenue growth for full-year 2026, ATS growth of at least 20%, continued modest gross margin expansion (~+50 bps expected full year), adjusted operating margin improvement, and adjusted diluted EPS growth of over 10%. Cash was $578M, and the company returned $102M to shareholders in the quarter (repurchases + dividends). Key investor takeaways: accelerating high-value, annuitized AI/agentic revenue that is improving revenue quality and margins; strong pipeline and large-deal momentum; deliberate shift to non-FTE, outcome-based commercial models; and conservative-but-upgraded guidance underpinned by record backlog and partner alliances.
